The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
about
NMR studies of the relationship between the changes of membrane lipids and the cisplatin-resistance of A549/DDP cellsMolecular mechanisms of cisplatin resistance in cervical cancerA Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473).Physiologic and pathologic drug resistance in ovarian carcinoma--a hypothesis based on a clonal progression model.Selective loss of inner hair cells and type-I ganglion neurons in carboplatin-treated chinchillas. Mechanisms of damage and protection.Glutathione and drug resistance.Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cellsHigh expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapyAcquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenograftsCisplatin-DNA damage recognition proteins in human tumour extracts.Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy.Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesCellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents.Modulation of cisplatin cytotoxicity by sulphasalazineLack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels.The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patientsRelationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatinRole of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell linesImexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell linesStrong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancerHigh resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesisExpression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial InfusionNovel strategies for the treatment of small-cell lung carcinoma.Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer.Chemotherapy advances in small-cell lung cancerActivating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing.Metabolic Features of Cancer Treatment Resistance."Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183".Synthesis, characterization and in vitro antitumor activity of platinum(II) oxalato complexes involving 7-azaindole derivatives as coligands.A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.Antioxidant inhibitors potentiate the cytotoxicity of photodynamic therapy.The mechanism of action of platinum anticancer agents--what do we really know about it?Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
P2860
Q50432263-640B0987-D724-467C-92EA-147A6C17CE2BQ54602996-07390AC4-B35A-4A81-A56E-7E351FDC6C4FQ54811605-2B54FA1B-8AA7-42B3-A8C8-83DE25A5413BQ54896958-AEE38147-0B70-4E71-89CB-B1310854C6F8Q54902669-DBEBF2F3-FF01-47DC-89BE-B5701BE821DAQ54902670-6898F280-9D0D-433A-8805-640B9080F90AQ54937005-72289AFB-C769-424D-A031-644021619E87Q54948747-A26AB79A-6C79-4FCF-B904-5E7402032A4C
P1343
Q24794423-65F0C91D-2320-4CCB-88AB-3E6EE5A13CE7Q26746228-E097FC80-D9F5-4CA7-98F4-CA705B94C689Q33347267-30522F16-18BD-4DF6-AFF8-E6C88BAC4123Q33537387-0631E302-8F3F-4110-8596-854CC99F6499Q33936899-86FDC0EF-DAEC-41D0-AF7E-B3A99E3CDC7CQ34374824-B790C699-71E9-4AFB-9C2A-22A1F744224CQ34517743-2DB7C2B3-1589-462C-9680-AA9CC7802785Q35667409-CA25BA37-A421-43CE-BC84-F6660DE6F750Q35686424-4AE14FEF-5305-408F-877A-9FB74C7D6987Q35975934-A53CA0A0-A273-423A-AD44-FB6EED3F70F7Q35976534-F62171AB-2E3F-4025-ADE2-1ED1D9D8140AQ35977182-D404223E-C4C0-4B5E-8E69-FD764E1B1A4AQ35977240-BD2952BA-96B6-44F4-9503-CE0E28173CA1Q35978030-D5B4D49D-2C58-4881-B679-9BFEDEA797EBQ35994531-FCC36943-65C6-4766-8F34-95A84B9C6F59Q35994695-7B07AF44-D5F5-4F61-94EC-490152B1C8AAQ36079502-872DA0DD-2C24-431A-B8E2-3CAD4F002B44Q36079955-31110E27-B26B-4B17-9199-8B89665296D7Q36114681-8621D3B1-F315-4C07-ABDB-BD1587D3F7E0Q36135705-F72D9783-69EC-40C5-B31D-B63142D2A9F1Q36135710-5CE214A6-6C83-46C6-B95B-C5A7F91C9BF2Q36422416-F52C57CD-5AC8-436B-BE55-64AA8B585B29Q36619998-47F8C764-8094-4015-9469-BC051DFB2B22Q36648770-80A606FC-D406-4BF3-8BCC-68C4992DA61AQ36880024-2CADCFA3-E53F-4C3C-86AF-1A72CF1CF3EDQ36904012-9ABC1B87-CA45-4A11-BA73-B393F5A00D30Q36936167-C01386F0-1120-40B1-8C2F-261011599B9FQ37666690-99305C4A-811F-40D6-8F61-EFBFC8EB6BBCQ37892341-9BACB9A2-C4B8-4F4A-A843-B735F8A5914AQ38119531-569535FE-3756-48D2-9794-43B3BD571990Q38155856-7E8E97F4-E889-43CA-9DB3-071A7302CBE6Q38186660-7722D689-22B6-4246-BDFE-FFDA3493EB02Q38936264-3A7F7BDD-704C-492C-8676-D3F96C66A863Q38970000-0879539B-7A84-4257-B2F0-F4ED70730629Q38971086-72FDC948-FE33-48B4-89A8-27D25282721EQ39185534-64200261-C8EC-4A6C-B92A-7C8748B0CCF3Q39409301-2A21727A-DCDE-4B95-95B4-2B9DC36C584CQ39449678-F540AA02-A0E2-4816-89E6-9B43271B69F6Q39761150-34B54E37-D8B4-4524-AFB2-8B137C903281Q39771644-51AA1F94-4748-4D70-BB6D-BF8F1FF1CF6B
P2860
The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
The relationships between glut ...... ovarian carcinoma cell lines.
@ast
The relationships between glut ...... ovarian carcinoma cell lines.
@en
type
label
The relationships between glut ...... ovarian carcinoma cell lines.
@ast
The relationships between glut ...... ovarian carcinoma cell lines.
@en
prefLabel
The relationships between glut ...... ovarian carcinoma cell lines.
@ast
The relationships between glut ...... ovarian carcinoma cell lines.
@en
P2093
P2860
P4510
P356
P1476
The relationships between glut ...... ovarian carcinoma cell lines.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1991.279
P407
P577
1991-08-01T00:00:00Z
P5875
P6179
1038605775